Trial intelligence / Profile preview

Effects of Cannabis Administration Routes on Performance and PK

NCT02177513Phase 1Completed

Sponsor
National Institute on Drug Abuse
Start
Jun 2014
Primary completion
Apr 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of cannabis (5 arms), sponsored by National Institute on Drug Abuse. Primary endpoints: Cannabis' pharmacodynamic effects, Cannabis' pharmacokinetic profiles and 2 more. Started Jun 2014; status: completed.

02

Drugs

cannabis

Beyond the preview

Go deeper on NCT02177513.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02177513.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call